SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Coca-Cola Company (The). The Group's principal activities are manufacturing, distributing and marketing nonalcoholic beverage concentrates and syrups. The products of the Group include carbonated soft drinks and also various kinds of non carbonated beverages. The Group sells these beverages, concentrates and syrups to bottling and canning operations, distributors, fountain wholesalers and retailers. The other products marketed and distributed by the Group include juice drinks, sports drinks, water products, teas, coffees and other beverage products. The Group also has ownership interests in various canning and bottling operations. The operations of the Group are conducted in the United States, Europe, Eurasia, Middle East, Africa, Latin America and Asia.

Coca-Cola Co

Coca-Colas stronger-than-expected second-quarter results and raised full-year outlooksupported by higher beverage volumesdrove a rally to record highs. Traders praised the earnings momentum and defensive appeal, while others questioned the stocks elevated valuation and durability of the run.

StablecoinX, Inc. is an infrastructure software and services company. The firm is focusing on supporting the blockchain Ethena. The company was founded on July 7, 2025 and is headquartered in Frisco, TX.

StableCoinX Inc. - Ordinary Shares - Class A

USDE is drawing attention as a volatile crypto-treasury play tied to Ethenas ENA token: traders cite the companys large ENA holdings and a perceived discount to their value, while attributing potential upside to ENA strength and stablecoin growth. The bullish valuation case is contested by concerns about warrant-related dilution, offerings, and sharp pullbacks.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention centers on TG Therapeutics scheduled MSToronto data presentations, especially late-breaking initial azer-cel findings in progressive MS, alongside BRIUMVI single-dose Phase 3 and long-term data. Traders largely view the presentations and the later subcutaneous BRIUMVI readout as potential catalysts, while speculation about a buyout and short-covering remains unconfirmed.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ais rebound has traders focused on a possible technical breakout and short-covering, with speculation amplified by the stocks sizable short interest. Bulls point to enterprise AI demand and customer wins, while skeptics question whether the rally is sustainable given the companys weak revenue and profitability record.

TELUS Corp. is a telecommunications company, which engages in the provision of telecommunication services and products primarily for wireless and wireline voice and data. It operates through TELUS Technology Solutions (TTech) and Digitally-led Customer Experiences–TELUS International (DLCX) segments. The TTech segment includes network revenues and equipment sales arising from mobile technologies, data revenues, healthcare software and technology solutions, voice and other telecommunications services revenues, and equipment sales. The DLCX segment is composed of digital customer experience and digital-enablement transformation solutions, including artificial intelligence and content management solutions, provided by TELUS International. The company was founded on October 4, 1990 and is headquartered in Vancouver, Canada.

Telus Corp.

TELUS is drawing attention after a steep selloff tied to a sharply reduced dividend and weak results. Traders debate whether the reset will help address heavy debt or reflects deeper business problems; some see value in the lower share price, while others remain concerned about management, competition and AI spending.

Devon Energy Corp. engages in the exploration, development, and production of oil and natural gas properties. It develops and operates Delaware Basin, Eagle Ford, Heavy Oil, Barnett Shale, STACK, and Rockies Oil. The company was founded by J. Larry Nichols and John W. Nichols in 1971 and is headquartered in Oklahoma City, OK.

Devon Energy Corp.

Devons sale of its Eagle Ford assets to Crescent Energy is drawing attention, with traders noting the assets represent a small share of production but questioning why the stock is falling despite the deal. Reactions are mixed between seeing the sale as meaningful asset monetization and criticizing DVNs persistent underperformance.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Attention centers on Corvus Phase 1 soquelitinib results in atopic dermatitis, which traders view as encouraging but preliminary. The shares weak reaction has fueled debate over the datas durability and significance, alongside speculation that elevated short interest is weighing on the stock.

XPeng, Inc. is a global physical AI company, which engages in bringing artificial intelligence into the physical world to reshape future mobility and smart living. It developed a full-stack physical AI architecture spanning Turing AI chips, world foundation models, and integrated software and hardware applications. The firm's product portfolio includes smart EVs, robotaxis, and humanoid robots. The company's sales and services drives continuous technological innovation and fosters an open physical AI ecosystem, making life smarter, safer, and better for users worldwide. XPeng, Inc. was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPengs push to license its vehicle architecture, AI chips and driver-assistance technology to automakers beyond Volkswagen, alongside a role in international autonomous-driving standards, is drawing attention. Bulls see potential in its technology and robotics businesses, while skeptics point to weak Chinese EV sentiment, profitability concerns and the stocks prolonged decline.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

Middle East conflict and threats to oil shipping and infrastructure, particularly around the Strait of Hormuz and Saudi routes, are driving attention to energy stocks; traders also point to tight refined-fuel supplies, including diesel. The community is divided between those expecting geopolitical supply risks to support energy and those betting that diplomacy or easing tensions will pull oil lower, with some frustrated that XLE has not tracked crude consistently.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is drawing attention as gold rebounds after a sharp selloff that traders linked to rising Treasury yields, a stronger dollar, and expectations for further Fed tightening. Bulls see signs of a bottom and trend recovery, while skeptics warn the bounce may fade if rates remain elevated.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amanta Healthcare Ltd. is a pharmaceutical company, which engages in the manufacturing and sale of pharmaceutical products. It focuses on developing, manufacturing, and marketing a diverse range of sterile liquid products-parenteral products. Its products include formulation, fluid therapy, diluents, respules, injections, ophthalmics, and medical devices. It operates through the India and Outside India geographical segments. The company was founded by Bhavesh Girishbhai Patel on December 21, 1994 and is headquartered in Ahmedabad, India.

Current Price	186.93
Prev Close	196.73
Open	196.00
Dividend Yield	0.00%
50-Day Moving Average	185.50
Beta	0.16
Avg. Volume	28,203.24
PE Ratio	49.58

52-Week High	209.95
52-Week Low	92.00
Market Capitalization	7.34B
EPS (Annual)	4.33
Price to Book	3.30
Revenue Per Employee	1.65M

Feed

News

Sentiment

Fundamentals

Info

AMANTA.NSE Fundamentals